CareDx (CDNA) Tops Q3 EPS by 6c

CareDx (NASDAQ: CDNA) reported Q3 EPS of $0.07, $0.06 better than the analyst estimate of $0.01. Revenue for the quarter came in at $75.6 million versus the consensus estimate of $74.05 million.

GUIDANCE:

CareDx sees FY2021 revenue of $290-293 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
• Honeywell Technologies sets three-year targets ahead of aerospace spin-off
• United Natural Foods (UNFI) Reports In-Line Q3 EPS ; Offers Outlook